Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123183) titled 'Physician and patient preferences of adjuvant therapy in early-stage Chinese RCC' on April 22.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Fudan University Shanghai Cancer Center
Condition:
Renal Cell Carcinoma (RCC)
Intervention:
Patients group:Not Applicable
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-22
Target Sample Size: Patients group:250;Doctors group:250;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=318179
Published by HT Digital Content Services with permission from H...